Studies in patients with NMDAR antibody-associated autoimmune encephalitis have shown an increase in serum IL-2 [172] and CSF IL-6, IL-17, CXCL-10, and IL-1β. This evidence concerns the gene IL17A and autoimmune encephalitis.